世界の好酸球性肉芽腫症市場2021-2026:経口、静脈内、その他

LP Informationが発行した調査報告書(LPI21MY9520)
◆英語タイトル:Global Eosinophilic Granulomatosis Market Growth 2021-2026
◆商品コード:LPI21MY9520
◆発行会社(リサーチ会社):LP Information
◆発行日:2021年5月(※2024年版があります。お問い合わせください)
◆ページ数:133
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2-3営業日)
◆調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥541,680見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥812,520見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥1,083,360見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はLP Information社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。LP Information社の概要及び新刊レポートはこちらでご確認いただけます。

LPインフォメーション社の「好酸球性肉芽腫症の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、経口、静脈内、その他など、用途別には、病院薬局、ドラッグストア、その他などにセグメント区分してまとめました。好酸球性肉芽腫症のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。
・好酸球性肉芽腫症の世界市場概要(サマリー)
・好酸球性肉芽腫症の企業別販売量・売上
・好酸球性肉芽腫症の企業別市場シェア
・好酸球性肉芽腫症の世界市場規模 2016年-2021年:種類別(経口、静脈内、その他)
・好酸球性肉芽腫症の世界市場規模 2016年-2021年:用途別(病院薬局、ドラッグストア、その他)
・好酸球性肉芽腫症の南北アメリカ市場規模(アメリカ、カナダ、メキシコなど)
・好酸球性肉芽腫症のアジア市場規模(日本、中国、韓国、インド、東南アジアなど)
・好酸球性肉芽腫症のヨーロッパ市場規模(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・好酸球性肉芽腫症の中東・アフリカ市場(エジプト、南アフリカ、トルコ、GCC諸国など)
・好酸球性肉芽腫症市場の成長要因・課題・動向
・好酸球性肉芽腫症の世界市場予測 2021年-2026年
・好酸球性肉芽腫症の南北アメリカ市場予測(アメリカ、カナダ、メキシコなど)
・好酸球性肉芽腫症のアジア市場予測(日本、中国、韓国、インド、東南アジアなど)
・好酸球性肉芽腫症のヨーロッパ市場予測(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・好酸球性肉芽腫症の中東・アフリカ市場予測(エジプト、南アフリカ、トルコ、GCC諸国など)
・好酸球性肉芽腫症の世界市場予測:種類別(経口、静脈内、その他)
・好酸球性肉芽腫症の世界市場予測:用途別(病院薬局、ドラッグストア、その他)
・主要企業分析
【レポートの概要】

According to this latest study, the 2020 growth of Eosinophilic Granulomatosis will have significant change from previous year. By the most conservative estimates of global Eosinophilic Granulomatosis market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Eosinophilic Granulomatosis market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Eosinophilic Granulomatosis market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Oral
Intravenous
Others

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Hospital Pharmacies
Drug Stores
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
GlaxoSmithKline
Pharmaceuticals Holdings
Baxter
Genentech(Roche)
Cephalon(Teva)
Amgen
Sanofi
DSM
AstraZeneca
Novartis International

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Eosinophilic Granulomatosis Consumption 2016-2026
2.1.2 Eosinophilic Granulomatosis Consumption CAGR by Region
2.2 Eosinophilic Granulomatosis Segment by Type
2.2.1 Oral
2.2.2 Intravenous
2.2.3 Others
2.3 Eosinophilic Granulomatosis Sales by Type
2.3.1 Global Eosinophilic Granulomatosis Sales Market Share by Type (2016-2021)
2.3.2 Global Eosinophilic Granulomatosis Revenue and Market Share by Type (2016-2021)
2.3.3 Global Eosinophilic Granulomatosis Sale Price by Type (2016-2021)
2.4 Eosinophilic Granulomatosis Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Drug Stores
2.4.3 Others
2.5 Eosinophilic Granulomatosis Sales by Application
2.5.1 Global Eosinophilic Granulomatosis Sale Market Share by Application (2016-2021)
2.5.2 Global Eosinophilic Granulomatosis Revenue and Market Share by Application (2016-2021)
2.5.3 Global Eosinophilic Granulomatosis Sale Price by Application (2016-2021)

3 Global Eosinophilic Granulomatosis by Company
3.1 Global Eosinophilic Granulomatosis Sales Market Share by Company
3.1.1 Global Eosinophilic Granulomatosis Sales by Company (2019-2021)
3.1.2 Global Eosinophilic Granulomatosis Sales Market Share by Company (2019-2021)
3.2 Global Eosinophilic Granulomatosis Revenue Market Share by Company
3.2.1 Global Eosinophilic Granulomatosis Revenue by Company (2019-2021)
3.2.2 Global Eosinophilic Granulomatosis Revenue Market Share by Company (2019-2021)
3.3 Global Eosinophilic Granulomatosis Sale Price by Company
3.4 Global Manufacturers Eosinophilic Granulomatosis Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Eosinophilic Granulomatosis Product Location Distribution
3.4.2 Players Eosinophilic Granulomatosis Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Eosinophilic Granulomatosis by Region
4.1 Global Eosinophilic Granulomatosis by Region
4.1.1 Global Eosinophilic Granulomatosis Sales by Region
4.1.2 Global Eosinophilic Granulomatosis Revenue by Region
4.2 Americas Eosinophilic Granulomatosis Sales Growth
4.3 APAC Eosinophilic Granulomatosis Sales Growth
4.4 Europe Eosinophilic Granulomatosis Sales Growth
4.5 Middle East & Africa Eosinophilic Granulomatosis Sales Growth

5 Americas
5.1 Americas Eosinophilic Granulomatosis Sales by Country
5.1.1 Americas Eosinophilic Granulomatosis Sales by Country (2016-2021)
5.1.2 Americas Eosinophilic Granulomatosis Revenue by Country (2016-2021)
5.2 Americas Eosinophilic Granulomatosis Sales by Type
5.3 Americas Eosinophilic Granulomatosis Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Eosinophilic Granulomatosis Sales by Region
6.1.1 APAC Eosinophilic Granulomatosis Sales by Region (2016-2021)
6.1.2 APAC Eosinophilic Granulomatosis Revenue by Region (2016-2021)
6.2 APAC Eosinophilic Granulomatosis Sales by Type
6.3 APAC Eosinophilic Granulomatosis Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Eosinophilic Granulomatosis by Country
7.1.1 Europe Eosinophilic Granulomatosis Sales by Country (2016-2021)
7.1.2 Europe Eosinophilic Granulomatosis Revenue by Country (2016-2021)
7.2 Europe Eosinophilic Granulomatosis Sales by Type
7.3 Europe Eosinophilic Granulomatosis Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Eosinophilic Granulomatosis by Country
8.1.1 Middle East & Africa Eosinophilic Granulomatosis Sales by Country (2016-2021)
8.1.2 Middle East & Africa Eosinophilic Granulomatosis Revenue by Country (2016-2021)
8.2 Middle East & Africa Eosinophilic Granulomatosis Sales by Type
8.3 Middle East & Africa Eosinophilic Granulomatosis Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Eosinophilic Granulomatosis Distributors
10.3 Eosinophilic Granulomatosis Customer

11 Global Eosinophilic Granulomatosis Market Forecast
11.1 Global Eosinophilic Granulomatosis Forecast by Region
11.1.1 Global Eosinophilic Granulomatosis Forecast by Regions (2021-2026)
11.2.2 Global Eosinophilic Granulomatosis Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Eosinophilic Granulomatosis Forecast by Type
11.7 Global Eosinophilic Granulomatosis Forecast by Application

12 Key Players Analysis
12.1 GlaxoSmithKline
12.1.1 GlaxoSmithKline GlaxoSmithKline Company Information
12.1.2 GlaxoSmithKline Eosinophilic Granulomatosis Product Offered
12.1.3 GlaxoSmithKline Eosinophilic Granulomatosis Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 GlaxoSmithKline Main Business Overview
12.1.5 GlaxoSmithKline Latest Developments
12.2 Pharmaceuticals Holdings
12.2.1 Pharmaceuticals Holdings Company Information
12.2.2 Pharmaceuticals Holdings Eosinophilic Granulomatosis Product Offered
12.2.3 Pharmaceuticals Holdings Eosinophilic Granulomatosis Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Pharmaceuticals Holdings Main Business Overview
12.2.5 Pharmaceuticals Holdings Latest Developments
12.3 Baxter
12.3.1 Baxter Company Information
12.3.2 Baxter Eosinophilic Granulomatosis Product Offered
12.3.3 Baxter Eosinophilic Granulomatosis Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Baxter Main Business Overview
12.3.5 Baxter Latest Developments
12.4 Genentech(Roche)
12.4.1 Genentech(Roche) Company Information
12.4.2 Genentech(Roche) Eosinophilic Granulomatosis Product Offered
12.4.3 Genentech(Roche) Eosinophilic Granulomatosis Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Genentech(Roche) Main Business Overview
12.4.5 Genentech(Roche) Latest Developments
12.5 Cephalon(Teva)
12.5.1 Cephalon(Teva) Company Information
12.5.2 Cephalon(Teva) Eosinophilic Granulomatosis Product Offered
12.5.3 Cephalon(Teva) Eosinophilic Granulomatosis Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Cephalon(Teva) Main Business Overview
12.5.5 Cephalon(Teva) Latest Developments
12.6 Amgen
12.6.1 Amgen Company Information
12.6.2 Amgen Eosinophilic Granulomatosis Product Offered
12.6.3 Amgen Eosinophilic Granulomatosis Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Amgen Main Business Overview
12.6.5 Amgen Latest Developments
12.7 Sanofi
12.7.1 Sanofi Company Information
12.7.2 Sanofi Eosinophilic Granulomatosis Product Offered
12.7.3 Sanofi Eosinophilic Granulomatosis Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Sanofi Main Business Overview
12.7.5 Sanofi Latest Developments
12.8 DSM
12.8.1 DSM Company Information
12.8.2 DSM Eosinophilic Granulomatosis Product Offered
12.8.3 DSM Eosinophilic Granulomatosis Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 DSM Main Business Overview
12.8.5 DSM Latest Developments
12.9 AstraZeneca
12.9.1 AstraZeneca Company Information
12.9.2 AstraZeneca Eosinophilic Granulomatosis Product Offered
12.9.3 AstraZeneca Eosinophilic Granulomatosis Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 AstraZeneca Main Business Overview
12.9.5 AstraZeneca Latest Developments
12.10 Novartis International
12.10.1 Novartis International Company Information
12.10.2 Novartis International Eosinophilic Granulomatosis Product Offered
12.10.3 Novartis International Eosinophilic Granulomatosis Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Novartis International Main Business Overview
12.10.5 Novartis International Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Eosinophilic Granulomatosis Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Oral
Table 3. Major Players of Intravenous
Table 4. Major Players of Others
Table 5. Global Eosinophilic Granulomatosis Sales by Type (2016-2021) & (Kiloton)
Table 6. Global Eosinophilic Granulomatosis Sales Market Share by Type (2016-2021)
Table 7. Global Eosinophilic Granulomatosis Revenue by Type (2016-2021) & ($ million)
Table 8. Global Eosinophilic Granulomatosis Revenue Market Share by Type (2016-2021)
Table 9. Global Eosinophilic Granulomatosis Sale Price by Type (2016-2021)
Table 10. Global Eosinophilic Granulomatosis Sales by Application (2016-2021) & (Kiloton)
Table 11. Global Eosinophilic Granulomatosis Sales Market Share by Application (2016-2021)
Table 12. Global Eosinophilic Granulomatosis Value by Application (2016-2021)
Table 13. Global Eosinophilic Granulomatosis Revenue Market Share by Application (2016-2021)
Table 14. Global Eosinophilic Granulomatosis Sale Price by Application (2016-2021)
Table 15. Global Eosinophilic Granulomatosis Sales by Company (2019-2021) & (Kiloton)
Table 16. Global Eosinophilic Granulomatosis Sales Market Share by Company (2019-2021)
Table 17. Global Eosinophilic Granulomatosis Revenue by Company (2019-2021) ($ Millions)
Table 18. Global Eosinophilic Granulomatosis Revenue Market Share by Company (2019-2021)
Table 19. Global Eosinophilic Granulomatosis Sale Price by Company (2019-2021)
Table 20. Key Manufacturers Eosinophilic Granulomatosis Producing Area Distribution and Sales Area
Table 21. Players Eosinophilic Granulomatosis Products Offered
Table 22. Eosinophilic Granulomatosis Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Eosinophilic Granulomatosis Sales by Region (2016-2021) (Kiloton)
Table 26. Global Eosinophilic Granulomatosis Sales Market Share by Region (2016-2021)
Table 27. Global Eosinophilic Granulomatosis Revenue by Region (2016-2021) & ($ Millions)
Table 28. Global Eosinophilic Granulomatosis Revenue Market Share by Region (2016-2021)
Table 29. Americas Eosinophilic Granulomatosis Sales by Country (2016-2021) & (Kiloton)
Table 30. Americas Eosinophilic Granulomatosis Sales Market Share by Country (2016-2021)
Table 31. Americas Eosinophilic Granulomatosis Revenue by Country (2016-2021) & ($ Millions)
Table 32. Americas Eosinophilic Granulomatosis Revenue Market Share by Country (2016-2021)
Table 33. Americas Eosinophilic Granulomatosis Sales by Type (2016-2021) & (Kiloton)
Table 34. Americas Eosinophilic Granulomatosis Sales Market Share by Type (2016-2021)
Table 35. Americas Eosinophilic Granulomatosis Sales by Application (2016-2021) & (Kiloton)
Table 36. Americas Eosinophilic Granulomatosis Sales Market Share by Application (2016-2021)
Table 37. APAC Eosinophilic Granulomatosis Sales by Region (2016-2021) & (Kiloton)
Table 38. APAC Eosinophilic Granulomatosis Sales Market Share by Region (2016-2021)
Table 39. APAC Eosinophilic Granulomatosis Revenue by Region (2016-2021) & ($ Millions)
Table 40. APAC Eosinophilic Granulomatosis Revenue Market Share by Region (2016-2021)
Table 41. APAC Eosinophilic Granulomatosis Sales by Type (2016-2021) & (Kiloton)
Table 42. APAC Eosinophilic Granulomatosis Sales Market Share by Type (2016-2021)
Table 43. APAC Eosinophilic Granulomatosis Sales by Application (2016-2021) & (Kiloton)
Table 44. APAC Eosinophilic Granulomatosis Sales Market Share by Application (2016-2021)
Table 45. Europe Eosinophilic Granulomatosis Sales by Country (2016-2021) & (Kiloton)
Table 46. Europe Eosinophilic Granulomatosis Sales Market Share by Country (2016-2021)
Table 47. Europe Eosinophilic Granulomatosis Revenue by Country (2016-2021) & ($ Millions)
Table 48. Europe Eosinophilic Granulomatosis Revenue Market Share by Country (2016-2021)
Table 49. Europe Eosinophilic Granulomatosis Sales by Type (2016-2021) & (Kiloton)
Table 50. Europe Eosinophilic Granulomatosis Sales Market Share by Type (2016-2021)
Table 51. Europe Eosinophilic Granulomatosis Sales by Application (2016-2021) & (Kiloton)
Table 52. Europe Eosinophilic Granulomatosis Sales Market Share by Application (2016-2021)
Table 53. Middle East & Africa Eosinophilic Granulomatosis Sales by Country (2016-2021) & (Kiloton)
Table 54. Middle East & Africa Eosinophilic Granulomatosis Sales Market Share by Country (2016-2021)
Table 55. Middle East & Africa Eosinophilic Granulomatosis Revenue by Country (2016-2021) & ($ Millions)
Table 56. Middle East & Africa Eosinophilic Granulomatosis Revenue Market Share by Country (2016-2021)
Table 57. Middle East & Africa Eosinophilic Granulomatosis Sales by Type (2016-2021) & (Kiloton)
Table 58. Middle East & Africa Eosinophilic Granulomatosis Sales Market Share by Type (2016-2021)
Table 59. Middle East & Africa Eosinophilic Granulomatosis Sales by Application (2016-2021) & (Kiloton)
Table 60. Middle East & Africa Eosinophilic Granulomatosis Sales Market Share by Application (2016-2021)
Table 61. Global Eosinophilic Granulomatosis Sales Forecast by Type (2021-2026) & (Kiloton)
Table 62. Global Eosinophilic Granulomatosis Sales Market Share Forecast by Type (2021-2026)
Table 63. Global Eosinophilic Granulomatosis Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 64. Global Eosinophilic Granulomatosis Revenue Market Share Forecast by Type (2021-2026)
Table 65. Global Eosinophilic Granulomatosis Sales Forecast by Application (2021-2026) & (Kiloton)
Table 66. Global Eosinophilic Granulomatosis Sales Market Share Forecast by Application (2021-2026)
Table 67. Global Eosinophilic Granulomatosis Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 68. Global Eosinophilic Granulomatosis Revenue Market Share Forecast by Application (2021-2026)
Table 69. GlaxoSmithKline Basic Information, Eosinophilic Granulomatosis Manufacturing Base, Sales Area and Its Competitors
Table 70. GlaxoSmithKline Eosinophilic Granulomatosis Product Offered
Table 71. GlaxoSmithKline Eosinophilic Granulomatosis Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 72. GlaxoSmithKline Main Business
Table 73. GlaxoSmithKline Latest Developments
Table 74. Pharmaceuticals Holdings Basic Information, Eosinophilic Granulomatosis Manufacturing Base, Sales Area and Its Competitors
Table 75. Pharmaceuticals Holdings Eosinophilic Granulomatosis Product Offered
Table 76. Pharmaceuticals Holdings Eosinophilic Granulomatosis Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 77. Pharmaceuticals Holdings Main Business
Table 78. Pharmaceuticals Holdings Latest Developments
Table 79. Baxter Basic Information, Eosinophilic Granulomatosis Manufacturing Base, Sales Area and Its Competitors
Table 80. Baxter Eosinophilic Granulomatosis Product Offered
Table 81. Baxter Eosinophilic Granulomatosis Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 82. Baxter Main Business
Table 83. Baxter Latest Developments
Table 84. Genentech(Roche) Basic Information, Eosinophilic Granulomatosis Manufacturing Base, Sales Area and Its Competitors
Table 85. Genentech(Roche) Eosinophilic Granulomatosis Product Offered
Table 86. Genentech(Roche) Eosinophilic Granulomatosis Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 87. Genentech(Roche) Main Business
Table 88. Genentech(Roche) Latest Developments
Table 89. Cephalon(Teva) Basic Information, Eosinophilic Granulomatosis Manufacturing Base, Sales Area and Its Competitors
Table 90. Cephalon(Teva) Eosinophilic Granulomatosis Product Offered
Table 91. Cephalon(Teva) Eosinophilic Granulomatosis Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 92. Cephalon(Teva) Main Business
Table 93. Cephalon(Teva) Latest Developments
Table 94. Amgen Basic Information, Eosinophilic Granulomatosis Manufacturing Base, Sales Area and Its Competitors
Table 95. Amgen Eosinophilic Granulomatosis Product Offered
Table 96. Amgen Eosinophilic Granulomatosis Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 97. Amgen Main Business
Table 98. Amgen Latest Developments
Table 99. Sanofi Basic Information, Eosinophilic Granulomatosis Manufacturing Base, Sales Area and Its Competitors
Table 100. Sanofi Eosinophilic Granulomatosis Product Offered
Table 101. Sanofi Eosinophilic Granulomatosis Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 102. Sanofi Main Business
Table 103. Sanofi Latest Developments
Table 104. DSM Basic Information, Eosinophilic Granulomatosis Manufacturing Base, Sales Area and Its Competitors
Table 105. DSM Eosinophilic Granulomatosis Product Offered
Table 106. DSM Eosinophilic Granulomatosis Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 107. DSM Main Business
Table 108. DSM Latest Developments
Table 109. AstraZeneca Basic Information, Eosinophilic Granulomatosis Manufacturing Base, Sales Area and Its Competitors
Table 110. AstraZeneca Eosinophilic Granulomatosis Product Offered
Table 111. AstraZeneca Eosinophilic Granulomatosis Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 112. AstraZeneca Main Business
Table 113. AstraZeneca Latest Developments
Table 114. Novartis International Basic Information, Eosinophilic Granulomatosis Manufacturing Base, Sales Area and Its Competitors
Table 115. Novartis International Eosinophilic Granulomatosis Product Offered
Table 116. Novartis International Eosinophilic Granulomatosis Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 117. Novartis International Main Business
Table 118. Novartis International Latest Developments
List of Figures
Figure 1. Picture of Eosinophilic Granulomatosis
Figure 2. Eosinophilic Granulomatosis Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Eosinophilic Granulomatosis Sales Growth Rate 2016-2026 (Kiloton)
Figure 7. Global Eosinophilic Granulomatosis Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Eosinophilic Granulomatosis Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Oral
Figure 10. Product Picture of Intravenous
Figure 11. Product Picture of Others
Figure 12. Global Eosinophilic Granulomatosis Sales Market Share by Type in 2020
Figure 13. Global Eosinophilic Granulomatosis Revenue Market Share by Type (2016-2021)
Figure 14. Eosinophilic Granulomatosis Consumed in Hospital Pharmacies
Figure 15. Global Eosinophilic Granulomatosis Market: Hospital Pharmacies (2016-2021) & (Kiloton)
Figure 16. Eosinophilic Granulomatosis Consumed in Drug Stores
Figure 17. Global Eosinophilic Granulomatosis Market: Drug Stores (2016-2021) & (Kiloton)
Figure 18. Eosinophilic Granulomatosis Consumed in Others
Figure 19. Global Eosinophilic Granulomatosis Market: Others (2016-2021) & (Kiloton)
Figure 20. Global Eosinophilic Granulomatosis Sales Market Share by Application (2016-2021)
Figure 21. Global Eosinophilic Granulomatosis Revenue Market Share by Application in 2020
Figure 22. Global Eosinophilic Granulomatosis Revenue Market by Company in 2020 ($ Million)
Figure 23. Global Eosinophilic Granulomatosis Revenue Market Share by Company in 2020
Figure 24. Global Eosinophilic Granulomatosis Sales Market Share by Regions (2016-2021)
Figure 25. Global Eosinophilic Granulomatosis Revenue Market Share by Region in 2020
Figure 26. Americas Eosinophilic Granulomatosis Sales 2016-2021 (Kiloton)
Figure 27. Americas Eosinophilic Granulomatosis Revenue 2016-2021 ($ Millions)
Figure 28. APAC Eosinophilic Granulomatosis Sales 2016-2021 (Kiloton)
Figure 29. APAC Eosinophilic Granulomatosis Revenue 2016-2021 ($ Millions)
Figure 30. Europe Eosinophilic Granulomatosis Sales 2016-2021 (Kiloton)
Figure 31. Europe Eosinophilic Granulomatosis Revenue 2016-2021 ($ Millions)
Figure 32. Middle East & Africa Eosinophilic Granulomatosis Sales 2016-2021 (Kiloton)
Figure 33. Middle East & Africa Eosinophilic Granulomatosis Revenue 2016-2021 ($ Millions)
Figure 34. Americas Eosinophilic Granulomatosis Sales Market Share by Country in 2020
Figure 35. Americas Eosinophilic Granulomatosis Revenue Market Share by Country in 2020
Figure 36. Americas Eosinophilic Granulomatosis Sales Market Share by Type in 2020
Figure 37. Americas Eosinophilic Granulomatosis Sales Market Share by Application in 2020
Figure 38. United States Eosinophilic Granulomatosis Revenue Growth 2016-2021 ($ Millions)
Figure 39. Canada Eosinophilic Granulomatosis Revenue Growth 2016-2021 ($ Millions)
Figure 40. Mexico Eosinophilic Granulomatosis Revenue Growth 2016-2021 ($ Millions)
Figure 41. Brazil Eosinophilic Granulomatosis Revenue Growth 2016-2021 ($ Millions)
Figure 42. APAC Eosinophilic Granulomatosis Sales Market Share by Region in 2020
Figure 43. APAC Eosinophilic Granulomatosis Revenue Market Share by Regions in 2020
Figure 44. APAC Eosinophilic Granulomatosis Sales Market Share by Type in 2020
Figure 45. APAC Eosinophilic Granulomatosis Sales Market Share by Application in 2020
Figure 46. China Eosinophilic Granulomatosis Revenue Growth 2016-2021 ($ Millions)
Figure 47. Japan Eosinophilic Granulomatosis Revenue Growth 2016-2021 ($ Millions)
Figure 48. Korea Eosinophilic Granulomatosis Revenue Growth 2016-2021 ($ Millions)
Figure 49. Southeast Asia Eosinophilic Granulomatosis Revenue Growth 2016-2021 ($ Millions)
Figure 50. India Eosinophilic Granulomatosis Revenue Growth 2016-2021 ($ Millions)
Figure 51. Australia Eosinophilic Granulomatosis Revenue Growth 2016-2021 ($ Millions)
Figure 52. Europe Eosinophilic Granulomatosis Sales Market Share by Country in 2020
Figure 53. Europe Eosinophilic Granulomatosis Revenue Market Share by Country in 2020
Figure 54. Europe Eosinophilic Granulomatosis Sales Market Share by Type in 2020
Figure 55. Europe Eosinophilic Granulomatosis Sales Market Share by Application in 2020
Figure 56. Germany Eosinophilic Granulomatosis Revenue Growth 2016-2021 ($ Millions)
Figure 57. France Eosinophilic Granulomatosis Revenue Growth 2016-2021 ($ Millions)
Figure 58. UK Eosinophilic Granulomatosis Revenue Growth 2016-2021 ($ Millions)
Figure 59. Italy Eosinophilic Granulomatosis Revenue Growth 2016-2021 ($ Millions)
Figure 60. Russia Eosinophilic Granulomatosis Revenue Growth 2016-2021 ($ Millions)
Figure 61. Middle East & Africa Eosinophilic Granulomatosis Sales Market Share by Country in 2020
Figure 62. Middle East & Africa Eosinophilic Granulomatosis Revenue Market Share by Country in 2020
Figure 63. Middle East & Africa Eosinophilic Granulomatosis Sales Market Share by Type in 2020
Figure 64. Middle East & Africa Eosinophilic Granulomatosis Sales Market Share by Application in 2020
Figure 65. Egypt Eosinophilic Granulomatosis Revenue Growth 2016-2021 ($ Millions)
Figure 66. South Africa Eosinophilic Granulomatosis Revenue Growth 2016-2021 ($ Millions)
Figure 67. Israel Eosinophilic Granulomatosis Revenue Growth 2016-2021 ($ Millions)
Figure 68. Turkey Eosinophilic Granulomatosis Revenue Growth 2016-2021 ($ Millions)
Figure 69. GCC Country Eosinophilic Granulomatosis Revenue Growth 2016-2021 ($ Millions)
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles


【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の好酸球性肉芽腫症市場2021-2026:経口、静脈内、その他(Global Eosinophilic Granulomatosis Market Growth 2021-2026)]についてメールでお問い合わせはこちらでお願いします。